Study uses base editing to correct mutation that causes rare immune deficiency

A new UCLA-led study suggests that advanced genome editing technology could be used as a one-time treatment for the rare and deadly genetic disease CD3 delta severe combined immunodeficiency…
Read More

About The Author

Jonathan Jeriah

See author's posts